Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype in the RT3 and REMARC trials—A LYSA retrospective analysis
Alexandre Willaume(Périnatalité & Risques Toxiques), Laurent Pascal(Groupe Hospitalier de l'Institut Catholique de Lille), Catherine Thiéblemont(Université Paris Cité), Franck Morschhauser(Hôpital Claude Huriez), Loïc Chartier(The Lymphoma Academic Research Organisation), Olivier Casasnovas, Paul Blanc‐Durand(Hôpitaux Universitaires Henri-Mondor), Romain Ricci(The Lymphoma Academic Research Organisation), Fabrice Jardin(Laboratoire National Henri Becquerel), S. Amorim(Hôpital Saint-Vincent-de-Paul), Corinne Haïoun(Assistance Publique – Hôpitaux de Paris)
Cited by 0
Related Papers
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma
|The Journal of Experimental Medicine|2003|1.1k
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.
|Journal of Clinical Oncology|1997|706
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523